LD-2 disclosure · 4th Quarter - Termination
SHIRE PHARMACEUTICALS LLC
Client
- Description
- Biotechnology company.
- Location
- Massachusetts · United States of America
Registrant
- Description
- Consulting firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesBudget/Appropriations
Monitored H.R. 6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act and Continuing Appropriations Act. Monitored H.R. 695, Further Additional Continuing Appropriations Act of 2019.
LobbyistsRACHEL JONES HENSLER · MARY BETH SAVARY TAYLOR · EMILY PORTER · KATHERINE RAAB
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of the Vice President of the United States
Taxation/Internal Revenue Code
Monitor implementation of The Tax Cut and Jobs Act, as it relates to corporate tax reform, the taxation of multinationals, and the orphan drug tax credit.
LobbyistsRACHEL JONES HENSLER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of the Vice President of the United States
Health Issues
Orphan Drug Act and issues regarding access to care for those with rare diseases. H.R. 5803, SAFETY Act of 2018, S. 2680, Opioid Crisis Response Act of 2018, S. 2891, Fighting the Opioid Epidemic with Sunshine Act of 2018, S. 3000, Patient Advocacy Transparency Act, and H.R. 6, SUPPORT for Patients and Communities Act as they related to issues regarding controlled substances. Monitored issues related to newborn screening.
